Mai, David
Boyce, Tifara
Mehta, Aakash
Reff, Jordan
Scholler, John
Sheppard, Neil C.
June, Carl H.
Article History
Received: 28 April 2023
Accepted: 5 February 2024
First Online: 7 February 2024
Competing interests
: N.C.S. is a scientific co-founder and holds equity in Bluewhale Bio, is a scientific advisor for Tome Biosciences and Pan Cancer T, and holds equity in Tmunity Therapeutics, and Pfizer Inc. C.H.J. is a scientific co-founder and holds equity in Capstan Therapeutics, Dispatch Biotherapeutics and Bluewhale Bio. C.H.J. serves on the board of AC Immune and is a scientific advisor to BluesphereBio, Cabaletta, Carisma, Cartography, Cellares, Cellcarta, Celldex, Danaher, Decheng, ImmuneSensor, Kite, Poseida, Verismo, Viracta, and WIRB-Copernicus group. The other authors declare no competing interests.